In addition, the proportion of muscle-invasive bladder cancer was limited and ... value in locally advanced invasive or metastatic urothelial cancer.

Results from cohort 2 of the TROPHY-U-01 study showed that sacitizumab govitecan led to rapid responses in patients with ...

Treatment Options for Bladder Cancer: Bringing Life to Years of Sparse Options - Guru Sonpavde ...

Johnson & Johnson discontinues the Phase 3 SunRISe-2 trial for TAR-200 in bladder cancer, citing lack of superiority. Q3 ...

Final results from the SWOG S1011 randomized Phase III clinical trial, published in the New England Journal of Medicine, ...

Drug infusion therapy after surgery for urothelial carcinoma is an effective measure to reduce cancer recurrence ... covalently linked engineered small interfering RNA (SiRNA) that interferes with the ...

Metastatic transitional (urothelial) tract cancer refers to a cancer that has originated in the transitional epithelium, which lines the urinary tract, including the bladder, ureters, and renal pelvis ...

Patients with muscle-invasive bladder cancer experienced safe medical and surgical treatment with the NURE-combo.

The disease is caused by abnormal cellular growth leading to a malignant tumor. The most common sub-type of bladder cancer is transitional cell carcinoma (also called urothelial carcinoma), which ...

Enfortumab vedotin plus pembrolizumab was previously granted a priority review designation from the MHLW.